Cosopt
designed for ocular hypertension to relieve increased pressure.
Strengths: 2/0.5%
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Dorzolamide/Timolol
- Therapeutic class
Carbonic Anhydrase Inhibitor; Beta-blocker
- Pharmacological class
Sulfonamide; Non-selective Beta-blocker
- Precautions and warnings
may cause temporary blurred vision; remove contact lenses before application
- Minor side effects
eye pain; burning sensation; taste alteration
- Moderate side effects
conjunctivitis; blurred vision; dry eyes; blepharitis
- Dosage forms
Eye drops, solution
- Administration route
Ocular use
- Patient summary
designed for ocular hypertension to relieve increased pressure.
- Prescription status
POM
- Manufacturer
Santen
- Onset Time
1 hour
- Duration
12 hours
- Storage instructions
Store below 25°C.
- Drug interactions
systemic beta-blockers; calcium channel blockers
- Age restrictions
Not recommended for children.
- Pregnancy and breastfeeding
Pregnancy: Not recommended. Breastfeeding: Not recommended.
Contraindications
hypersensitivity to components; asthma; severe chronic obstructive pulmonary disease; bradycardia; second or third-degree heart block
Serious side effects
anaphylaxis — requires immediate medical attention; bradycardia — requires immediate medical attention
Mechanism of action
Cosopt contains a carbonic anhydrase inhibitor and a beta-blocker to lower eye pressure. It works by reducing the production of aqueous humour inside the eye, which helps maintain lower pressure levels and prevents potential damage to the optic nerve associated with intraocular pressure.
Cosopt
designed for ocular hypertension to relieve increased pressure.
Editorial Notes
- Active ingredient(s): Dorzolamide, Timolol
- Listed indication(s): Ocular Hypertension, Open-angle Glaucoma
Available option
- 3 bottles - 2/0.5 %1545-2-0-5-pct-18199